$8.84
+0.05(0.57%)
Mkt Cap $524M
$8.57
$15.31
52-Week Range
At A Glance
1
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes.
2
Revenue is primarily driven by Pen Needles (73.9%) and Safety (11.8%).
3
Most recently: . Results of Operations and Financial Condition. On February 5, 2026, Embecta Corp. issued a press release (the “Press Release”) regarding its results for the q (2026-02-05).
$524M
Market Cap
$1.1B
Revenue
$142M
Net Income
Employees2,000
Fundamentals
How The Business Makes Money
Revenue by Segment
Pen Needles73.9%($2.5B)
Safety11.8%($394M)
Syringes11.7%($389M)
Manufacturing Facility1.4%($46M)
Product And Service Other1.2%($39M)
Revenue by Geography
US53.8%($1.8B)
Non Us46.2%($1.5B)
Activity
What Changed Recently
Analyst View
Company Profile
CIK0001872789
ISINUS29082K1051
CUSIP29082K105
Phone201 847 6880
Address300 Kimball Drive, Parsippany, NJ, 07054, US
SEC EDGAR